Xenon Pharmaceuticals Inc (XENE)

Apr 18, 2025, 3:36 AM EDT - 6 days ago

Xenon- A Later Stage Story

Apr 4, 2025, 4:23 PM EDT - 19 days ago

Xenon Pharmaceuticals Looks Attractive Before Epilepsy Data

Apr 4, 2025, 8:30 AM EDT - 19 days ago

Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025

Mar 31, 2025, 2:05 PM EDT - 23 days ago

Stifel's Paul Matteis says look for biotech names not dependent on the FDA amid sector uncertainty

XBI ALNY RYTM VRTX

Mar 12, 2025, 4:01 PM EDT - 6 weeks ago

Xenon to Present at Stifel 2025 Virtual CNS Forum

Feb 27, 2025, 11:53 PM EST - 7 weeks ago

Xenon Pharmaceuticals Inc. (XENE) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 4:01 PM EST - 7 weeks ago

Xenon Reports Fourth Quarter & Full Year 2024 Financial Results and Business Update

Feb 25, 2025, 4:01 PM EST - 2 months ago

Xenon to Present at the 45th Annual TD Cowen Healthcare Conference

Feb 20, 2025, 4:01 PM EST - 2 months ago

Xenon to Report Q4 and Full Year 2024 Financial Results on February 27, 2025

Feb 12, 2025, 12:00 PM EST - 2 months ago

XENON Systems Partners with Netris to Deliver Multi-tenant GPU Cloud Networking Solutions for AI/ML Cloud Providers in the Region

Jan 16, 2025, 1:41 AM EST - 3 months ago

Xenon Pharmaceuticals: 2025 Could Be Pivotal For Azetukalner's Epilepsy Potential

Jan 13, 2025, 8:30 AM EST - 3 months ago

Xenon Outlines Key Corporate Milestone Opportunities for 2025

Jan 7, 2025, 8:30 AM EST - 3 months ago

Xenon to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 6, 2024, 4:01 PM EST - 4 months ago

Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024

Nov 25, 2024, 8:30 AM EST - 5 months ago

Xenon to Showcase New Long-Term Azetukalner Data at AES 2024

Nov 13, 2024, 4:01 PM EST - 5 months ago

Xenon to Present at Upcoming Investor Conferences

Nov 12, 2024, 10:49 PM EST - 5 months ago

Xenon Pharmaceuticals Inc. (XENE) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 4:01 PM EST - 5 months ago

Xenon Reports Q3 2024 Financial Results and Business Update

Nov 5, 2024, 4:01 PM EST - 6 months ago

Xenon to Report Q3 2024 Financial Results on November 12, 2024

Oct 2, 2024, 4:28 PM EDT - 7 months ago

Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual Conference

Sep 9, 2024, 8:30 AM EDT - 8 months ago

Xenon Showcases Azetukalner Data at 15th European Epilepsy Congress

Aug 9, 2024, 12:10 PM EDT - 9 months ago

Xenon Pharmaceuticals, Inc. (XENE) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:01 PM EDT - 9 months ago

Xenon Reports Q2 2024 Financial Results and Business Update

Aug 1, 2024, 4:01 PM EDT - 9 months ago

Xenon to Report Q2 2024 Financial Results on August 8, 2024

Jul 30, 2024, 7:30 AM EDT - 9 months ago

Xenon Gas Market to Reach USD 270.5 Million at a CAGR of 5.2% through 2034 Amid Bolstering Usage in MRI Scanning Machines and High-power Lamps | Future Market Insights, Inc.

Jun 5, 2024, 4:01 PM EDT - 11 months ago

Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

May 28, 2024, 8:30 AM EDT - 11 months ago

Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual Meeting

May 9, 2024, 4:01 PM EDT - 1 year ago

Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update

May 8, 2024, 4:01 PM EDT - 1 year ago

Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024

May 8, 2024, 9:02 AM EDT - 1 year ago

Polarean's Xenon MRI to be Featured at Upcoming ATS 2024 Conference

May 7, 2024, 4:01 PM EDT - 1 year ago

Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference

May 2, 2024, 4:01 PM EDT - 1 year ago

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update

Apr 16, 2024, 8:30 AM EDT - 1 year ago

Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting

Apr 10, 2024, 8:30 AM EDT - 1 year ago

Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Apr 4, 2024, 4:01 PM EDT - 1 year ago

Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference

Mar 12, 2024, 4:01 PM EDT - 1 year ago

Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days

Mar 5, 2024, 4:01 PM EST - 1 year ago

Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024

Feb 29, 2024, 10:16 PM EST - 1 year ago

Xenon Pharmaceuticals Inc. (XENE) Q4 2023 Earnings Call Transcript

Feb 29, 2024, 4:01 PM EST - 1 year ago

Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Feb 22, 2024, 4:01 PM EST - 1 year ago

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update

Jan 8, 2024, 8:00 AM EST - 1 year ago

Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2024

Jan 3, 2024, 8:30 AM EST - 1 year ago

Xenon Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Dec 4, 2023, 4:16 PM EST - 1 year ago

Xenon Pharmaceuticals Announces Closing of $345.0 Million Upsized Public Offering Including Full Exercise of the Underwriters' Option to Purchase Additional Shares

Dec 2, 2023, 12:01 PM EST - 1 year ago

Xenon Pharmaceuticals Provides Updates on Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2023)

Nov 29, 2023, 10:51 PM EST - 1 year ago

Xenon Pharmaceuticals Announces Pricing of Upsized $300.0 Million Public Offering

Nov 29, 2023, 4:03 PM EST - 1 year ago

Xenon Pharmaceuticals Announces Proposed Public Offering

Nov 27, 2023, 8:30 AM EST - 1 year ago

Xenon Pharmaceuticals' stock falls as depression treatment has mixed results in clinical trial

Nov 27, 2023, 7:43 AM EST - 1 year ago

Canada's Xenon Pharma's depression drug fails to meet main goal in study

Nov 27, 2023, 7:00 AM EST - 1 year ago

Xenon Pharmaceuticals Announces Topline Results from Phase 2 Proof-of-Concept X-NOVA Clinical Trial of XEN1101 in Major Depressive Disorder (MDD)

Nov 26, 2023, 4:55 AM EST - 1 year ago

Xenon Pharmaceuticals: XEN1101 Remains A Gem Despite The Dip